Goldman Sachs’s Guardian Pharmacy Services GRDN Stock Holding History

Goldman Sachs’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.7M	Sell	98,172 -42,008	-30%	-$1.37M	﹤0.01%	3983
2025 Q4	$4.22M	Buy	140,180 +6,109	+5%	+$173K	﹤0.01%	3898
2025 Q3	$3.52M	Buy	134,071 +116,483	+662%	+$2.78M	﹤0.01%	3967
2025 Q2	$375K	Buy	17,588 +2,073	+13%	+$46.8K	﹤0.01%	5328
2025 Q1	$330K	Sell	15,515 -155,351	-91%	-$3.19M	﹤0.01%	5410
2024 Q4	$3.46M	Buy	170,866 +130,866	+327%	+$2.7M	﹤0.01%	3810
2024 Q3	$672K	Buy	+40,000	New	+$674K	﹤0.01%	4889

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Goldman Sachs's GRDN Position: Q1 2026 in Review

Goldman Sachs reduced its Guardian Pharmacy Services (GRDN) stake by 30% in Q1 2026, selling an estimated $1.37M and leaving 98,172 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

Goldman Sachs first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.22M in Q4 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

Goldman Sachs held 98,172 shares of Guardian Pharmacy Services worth $3.7M as of Q1 2026.
Goldman Sachs sold 42,008 Guardian Pharmacy Services shares in Q1 2026, an estimated $1.37M.
Guardian Pharmacy Services made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3983 holding.
Goldman Sachs first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
Goldman Sachs's Guardian Pharmacy Services position peaked at $4.22M in Q4 2025.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.